FDA Inspection 1117444 — SGS Analytics Switzerland AG
The FDA completed an inspection of SGS Analytics Switzerland AG on Dec 13, 2019 in Birsfelden. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 13, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Birsfelden (Switzerland)
Additional details
Bioanalytical BA/BE